Want to join the conversation?
$LYB Form 4: On Aug. 12, 2015, Daniel Coombs, EVP – I&D, purchased 560 shares at $88.18 per share. Post transaction, Daniel currently owns 1,847 shares under direct ownership, which includes 1,287 RSUs granted pursuant to the issuer's long-term incentive plan on May 29, 2015 that vest on May 29, 2018.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.